Skip to content
healthcare.dev
Get a free key

Repaglinide

NDC 65862-670, Repaglinide, tablet, from Aurobindo Pharma Limited.

Product NDC
65862-670
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203820
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-670 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REPAGLINIDE.5 mg/1

Pharmacologic classes

Glinide [EPC]; Potassium Channel Antagonists [MoA]

Package NDCNDC-11Package
65862-670-0165862067001100 TABLET in 1 BOTTLE (65862-670-01)
65862-670-0565862067005500 TABLET in 1 BOTTLE (65862-670-05)
65862-670-99658620670991000 TABLET in 1 BOTTLE (65862-670-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/68064989-47ea-4ed5-a20e-43c4ef6ec271

  • NADAC price for package 65862067001

    GET /v1/drugs/nadac/65862067001

Use it

Look up 65862-670 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-670 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-670. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.